ATMA 2024 Roadmap
VirtualLocationThursday December 7, 2023 @ 6:00 pm – 7:00 pm MDT Join our network and begin offering psychedelic-assisted therapy to much needed […]
Thursday December 7, 2023 @ 6:00 pm – 7:00 pm MDT Join our network and begin offering psychedelic-assisted therapy to much needed […]
Sponsored by ATMA, this webinar will help assist practitioners wishing to provide Psychedelic-assisted therapy (PaT). This webinar will answer these 2 important […]
Register Here Embarking on the journey to become an effective compassionate witness in the psychedelic realm is akin to transforming into […]
Register Here Join Dr. Scott Shannon (MAPS principal investigator on its Phase 3 MDMA Clinical Trial), and ATMA CEO, Vu Tran to learn more about […]
Register Here Join us for an exclusive fireside chat with the visionary team behind the Psychedelic Puppet Show while we come […]
Register Here Join us on as epic visual trip as we talk to author, professor, and Canadian historian, Dr Erika Dyck about her […]
ATMA’s Phase II Psilocybin-assisted Therapy Clinical Trial has now received a No Objection Letter from Health Canada, as well as approval from […]
The group therapy hypothesis suggests that group sessions enhance social connectedness and well-being by fostering communitas, psychological safety, empathy, cooperation, and aiding […]
If you are a clinician, therapist, holistic practitioner, nurse, social worker, or a clinic owner interested in psychedelic-assisted therapy but don't […]
Join us for an insightful webinar designed to shed light on the essential factors that influence the coverage of psychedelic-assisted therapy […]
Unknotting the Mind A Guided Practice in Meditation and A Discussion on experiencing Freedom of Mind Meditation is such a generalized term […]
Unknotting the Mind A Guided Practice in Meditation and A Discussion on experiencing Freedom of Mind Meditation is such a generalized term […]